|
|
|
Insider
Information: |
Dethlefs Sven |
Relationship: |
EVP, North America Com... |
City: |
Petach Tikva |
State: |
L3 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
165,381 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,687,441 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
165,381 |
|
|
Total
Value |
$2,687,441 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Teva Pharmaceutical Industries L... |
TEVA |
EVP, North America Com... |
2023-03-07 |
165,381 |
2018-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2018-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,399 |
3,900 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2018-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,190 |
4,413 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2018-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,179 |
5,016 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2018-09-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,445 |
7,890 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2019-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,399 |
8,664 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2019-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,191 |
9,249 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2019-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,179 |
9,781 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2019-09-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,446 |
10,595 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2020-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,135 |
23,730 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2020-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,399 |
19,460 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2020-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,179 |
20,639 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2021-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
55,287 |
89,061 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2021-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,135 |
33,774 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,346 |
76,750 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2021-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
70,664 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2021-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,930 |
83,988 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
|
2022-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,135 |
91,111 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
|
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,346 |
104,319 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
|
2022-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
51,869 |
151,326 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
|
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,952 |
172,374 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
|
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
59,655 |
207,690 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
|
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
52,469 |
217,850 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP, North America Commercial |
|
2023-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,952 |
242,802 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2021-03-03 |
4 |
AS |
$10.86 |
$6,583 |
D/D |
(606) |
70,058 |
0 |
% |
|
TEVA |
Teva Pharmaceutical Indus... |
EVP Global Marketing&Portfolio |
|
2019-03-12 |
4 |
AS |
$15.67 |
$10,142 |
D/D |
(647) |
8,602 |
0 |
- |
|
43 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|